Malaria incidents are on the rise. Among children aged 5 and 17 months who received 4 doses of RTS,S, the vaccine prevented about 30% of them from developing severe malaria. Since 2019 more than 2 million children in Ghana, Kenya and Malawi have been vaccinated with the RTS,S malaria vaccine. The world’s largest vaccine manufacturer, the Serum Institute of India, …
A decades-long pursuit to disarm mosquitoes has produced new vaccines. In trials carried out between 2009 and 2011 across seven African countries, the RTS,S vaccine prevented infants from developing malaria for at least three years after the first vaccination. It is the number two cause of toddler deaths in Africa after respiratory illnesses – nearly half a million children die …
On 2 October 2023, when India celebrated both Gandhi and Lal Bahadur Shastri Jayanti, there was one more reason to celebrate this year. In April 2023, almost coinciding with World Malaria Day, the West African nation Ghana approved the malaria vaccine R21, even before it was approved by the WHO. The vaccine R21 is developed at the University of Oxford …
The World Health Organisation recommended the R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India for use as it met required safety, quality and effectiveness standards, according to a report by news agency ANI. The vaccine was recommended for use after a rigorous, detailed scientific review by the Strategic Advisory Group of Experts and …